Superion® Interspinous Spacer (ISS) is a motion-preserving, indirect decompression spinal implant system for the treatment of moderate lumbar spinal stenosis. Superion is the most advanced and least invasive ISS available or in development.
Benefits:
• One piece, expandable implant
• Minimally invasive midline approach
• Motion preserving
• Tissue sparing and fully reversible
The Superion ISS system is designed to deliver the implant through a single small incision in the patient’s back, utilizing VertiFlex’ proprietary interspinous access platform. The procedure can be performed under local anesthesia on an outpatient basis and closed with a single suture. Once in place, it may reduce pressure on the nerves that cause pain and allow the return to a more active lifestyle.Superion has been CE marked since 2007 and is currently an investigational device in the U.S. Enrollment completed in the Superion pivotal IDE trial with 470 patients in December, 2011. It has been implanted in over 2000 patients worldwide.To date, VertiFlex has compiled the largest, most rigorous, body of device clinical evidence, related to lumbar spinal stenosis.
About Interspinous Devices
Interspinous spacers sometimes also called as Interspinous process decompression systems, are the devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium) which is biocompatible in the human body. These devices are imbedded in body to confine painful motion else enabling normal motion and to treat lumbar spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and non-traumatic instability. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back which causes compression on nerves and it is developed gradually with age. Radiology tests are used to confirm a diagnosis of moderate degenerative lumbar spinal stenosis. People with lumbar spinal stenosis experience pain but may also have weakness in their leg, lower back and buttocks, numbness, tingling.
The Interspinous spacer are implanted between those vertebrae in such a way that it prevents the patient from bending too far backward which causes pain by surgical procedure. The procedure is very small and sometimes patient can go home within a day.The increasing prevalence of spinal stenosis due to aging, arthritis, heredity and increased demand of surgical procedures that improved lifestyle and comfort will drive the Interspinous spacer market. The adoption of spacers are increasing due to low complication rate as compared to decompression and spinal fusion. The Interspinous spacers are widely used in geriatric population as per Medicare data due to old age patient are not comfortable with surgery due to their health conditions. Source:Transparency Market Research (TMR)
About Vertiflex
Vertiflex is committed to delivering clinically proven treatments for lumbar stenosis that are minimally invasive in order to help people take back their lives. We believe there is a gap in the continuum of care between long-term pain management and traditional surgery. Our mission is to improve the standard of care with new solutions that put patient safety and comfort first. We are relentlessly focused on providing the most advanced, least invasive treatments for lumbar stenosis.http://www.vertiflexspine.com
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. On May 9, 2019 Boston Scientific announced a definitive agreement to acquire Vertiflex, Inc.